Articles & Research

Depression is a complex mental health condition that affects thousands of people in Virginia, and finding effective treatments can be a challenging journey. While traditional antidepressant medications and therapy are commonly prescribed, some individuals may not respond adequately to these approaches. In recent years, two innovative treatments have emerged as promising options for individuals with

Depression is a complex and challenging mental health condition that affects millions of people worldwide. While many individuals find relief through traditional antidepressant medications and therapy, some continue to struggle with symptoms despite trying multiple treatment approaches. For those facing treatment-resistant depression (TRD), esketamine therapy offers a ray of hope. What is Esketamine? Esketamine is

Esketamine has emerged as a groundbreaking treatment option for individuals struggling with treatment-resistant depression (TRD). Marketed under the brand name Spravato, esketamine represents a novel approach to depression management, offering hope to those who have not responded adequately to traditional antidepressant medications. At McLean Neuropsychiatric Treatment Center we explore what esketamine treatment entails, the role

Innovative treatments like Spravato are paving the way for transformative care. Spravato, a nasal spray derived from ketamine, has shown remarkable efficacy in treating conditions such as treatment-resistant depression. When seeking relief from the depths of mental health challenges, the quality of care received at a Spravato treatment center becomes paramount. We invite you to

In the dynamic landscape of neuropsychiatric treatment, a groundbreaking innovation has been making waves – Transcranial Magnetic Stimulation (TMS). This non-invasive procedure has emerged as a promising therapeutic intervention for a range of neuropsychiatric conditions, offering new hope to individuals facing challenges such as depression, anxiety, and other mental health disorders. McLean Neuropsychiatric Treatment Center

The quest for effective treatments for anxiety has led to groundbreaking innovations. Esketamine, a derivative of the anesthetic ketamine, has emerged as a promising therapy for those grappling with treatment-resistant anxiety. At McLean, we explore the intricacies of esketamine treatment, its mechanism of action, and the potential it holds for individuals facing the challenges of